Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
BLPH | Bellerophon Therapeutics, Inc. | Heyrman Reinilde | Chief Clinical Dev. Officer | Feb 19, 2015 | Buy | $12.00 | 1,500 | 18,000 | 9,483 | Feb 23, 2015, 09:40 PM |
Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
BLPH | Bellerophon Therapeutics, Inc. | Heyrman Reinilde | Chief Clinical Dev. Officer | Feb 19, 2015 | Buy | $12.00 | 1,500 | 18,000 | 9,483 | Feb 23, 2015, 09:40 PM |